Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Definitions
3. Major drivers for patient stratification
4. Technologies
5. Data integration is key
6. Breast cancer
7. Transcriptional profiling and breast cancer
8. Molecular profiling in NSCLC
9. FDA approves Crizotinib & companion test
10. Integration of molecular profiling into the clinic
11. Tumour sequencing for personalised oncology
12. Identification of genes affecting drug response
13. Recent advances in genetics for other diseases
14. Common alleles (MS)
15. ALS genetics
16. Future electronic health record
17. Thanks

Topics Covered

• Personalised medicine in Oncology
• Patient stratification using molecular markers
• Next generation genome sequencing and data handling
• Drivers of patient stratification including payors
• Molecular profiling in lung and breast cancer
• Relevance of these approaches for ALS, MS and other neurological diseases

Links

Series:

• Biomarkers

Categories:

• Cancer
• Clinical Practice

Therapeutic Areas:

• Oncology

Talk Citation

Harris, T. (2012, September 27). Patient stratification for drug treatment in oncology and other diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/OLAA5499.
Export Citation (RIS)

Publication History

• Published on September 27, 2012

Financial Disclosures

• Dr. Tim Harris, Stock Shareholder (Self-managed): Biogen Idec; Other: employee of Biogen Idec.